Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 19 (TMEM19) is a protein in humans encoded by the TMEM19 gene, located on chromosome 12q21.1[1][5]. The protein comprises 336 amino acids and features 6 transmembrane regions, with moderate expression in various tissues and highest levels reported in superior cervical ganglia and cardiac myocytes[1][4]. TMEM19 is annotated as a protein of unknown function (DUF92 family) and appears to associate with the cell membrane, with predicted activity based on computational models[3][5]. Associations have been made between TMEM19 genetic loci and non-syndromic cleft lip with palate as well as ammonia nitrogen tolerance, but no clear or direct therapeutic targeting roles or mechanistic disease implications have been established[1]. Protein–protein interaction data suggest TMEM19 interacts with a variety of membrane-associated proteins, but its precise function remains uncharacterized[1]. No known drugs or targeted therapies are reported, and there is no established role as a therapeutic target in the biomedical literature to date[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 19 (TMEM19).